"Macular Degeneration" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Degenerative changes in the RETINA usually of older adults which results in a loss of vision in the center of the visual field (the MACULA LUTEA) because of damage to the retina. It occurs in dry and wet forms.
| Descriptor ID |
D008268
|
| MeSH Number(s) |
C11.768.585.439
|
| Concept/Terms |
Macular Degeneration- Macular Degeneration
- Degeneration, Macular
- Degenerations, Macular
- Macular Degenerations
- Age-Related Maculopathies
- Age Related Maculopathies
- Macular Degeneration, Age-Related
- Macular Dystrophy
- Dystrophies, Macular
- Dystrophy, Macular
- Macular Dystrophies
- Maculopathies, Age-Related
- Maculopathies, Age Related
- Maculopathy, Age-Related
- Maculopathy, Age Related
- Age-Related Macular Degeneration
- Age Related Macular Degeneration
- Age-Related Macular Degenerations
- Degeneration, Age-Related Macular
- Degenerations, Age-Related Macular
- Macular Degenerations, Age-Related
- Age-Related Maculopathy
- Age Related Maculopathy
|
Below are MeSH descriptors whose meaning is more general than "Macular Degeneration".
Below are MeSH descriptors whose meaning is more specific than "Macular Degeneration".
This graph shows the total number of publications written about "Macular Degeneration" by people in this website by year, and whether "Macular Degeneration" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 2 | 0 | 2 |
| 1999 | 2 | 0 | 2 |
| 2000 | 2 | 0 | 2 |
| 2001 | 3 | 1 | 4 |
| 2002 | 1 | 0 | 1 |
| 2004 | 2 | 0 | 2 |
| 2007 | 0 | 1 | 1 |
| 2009 | 1 | 0 | 1 |
| 2010 | 2 | 0 | 2 |
| 2011 | 2 | 0 | 2 |
| 2012 | 2 | 0 | 2 |
| 2013 | 2 | 0 | 2 |
| 2014 | 3 | 1 | 4 |
| 2015 | 2 | 0 | 2 |
| 2016 | 3 | 0 | 3 |
| 2017 | 1 | 1 | 2 |
| 2018 | 3 | 0 | 3 |
| 2019 | 4 | 0 | 4 |
| 2020 | 2 | 0 | 2 |
| 2021 | 3 | 0 | 3 |
| 2022 | 4 | 0 | 4 |
| 2023 | 7 | 0 | 7 |
| 2024 | 4 | 0 | 4 |
| 2025 | 6 | 2 | 8 |
| 2026 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Macular Degeneration" by people in Profiles.
-
Dopamine-Enhancing Therapies and Risk of Neovascular AMD Conversion: A Target Trial Emulation. Am J Ophthalmol. 2026 Oct; 290:246-251.
-
Case series: The value of fundus autofluorescence in inherited macular disease. Optom Vis Sci. 2026 Mar; 103(3):e70036.
-
Avacincaptad Pegol for Geographic Atrophy Secondary to Age-Related Macular Degeneration: Two-Year Efficacy and Safety Results from the GATHER2 Phase 3 Trial. Ophthalmology. 2026 04; 133(4):451-465.
-
Consideration of patient phenotypes in geographic atrophy due to age-related macular degeneration. BMJ Open Ophthalmol. 2025 07 07; 10(1).
-
Ocular Phenotyping of Knockout Mice Identifies Genes Associated With Late Adult Retinal Phenotypes. Invest Ophthalmol Vis Sci. 2025 06 02; 66(6):64.
-
A deconvolution framework that uses single-cell sequencing plus a small benchmark data set for accurate analysis of cell type ratios in complex tissue samples. Genome Res. 2025 01 22; 35(1):147-161.
-
Photobiomodulation Therapy for Non-exudative Age-related Macular Degeneration. Int Ophthalmol Clin. 2025 Jan 01; 65(1):47-52.
-
QM107, a novel CD148 (RTP Type J) activating peptide therapy for treating neovascular age-related macular degeneration. Br J Pharmacol. 2025 Feb; 182(4):951-968.
-
Treatment Strategies for Anti-VEGF Resistance in Neovascular Age-Related Macular Degeneration by Targeting Arteriolar Choroidal Neovascularization. Biomolecules. 2024 02 21; 14(3).
-
Therapies for Geographic Atrophy. Int Ophthalmol Clin. 2024 01 01; 64(1):5-20.